{"nct_id":"NCT03551782","title":"A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2018-06-28","start_date_type":"ACTUAL","primary_completion_date":"2021-11-11","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}